ストックスクリーナーアプリを入手
139.37
2.64%
3.59
アフターアワーズ：
139.58
0.21
+0.15%
前日終値:
$135.78
開ける：
$135.45
24時間の取引高:
2.01M
Relative Volume:
1.08
時価総額：
$21.17B
収益：
$4.34B
当期純損益:
$850.00M
株価収益率:
25.51
EPS:
5.4635
ネットキャッシュフロー:
$921.00M
1週間 パフォーマンス:
+8.44%
1か月 パフォーマンス:
+9.41%
6か月 パフォーマンス:
+19.26%
1年 パフォーマンス:
+78.95%
1日の値動き範囲:
$133.97
$140.84
1週間の範囲:
$119.14
$140.84
52週間の値動き範囲:
$73.86
$155.53
Illumina Inc Stock (ILMN) Company Profile
Compare ILMN vs TMO, DHR, IDXX, A, NTRA
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
ILMN
Illumina Inc
|
139.37 | 20.63B | 4.34B | 850.00M | 921.00M | 5.4635 |
TMO
Thermo Fisher Scientific Inc
|
462.60 | 174.37B | 45.20B | 6.87B | 6.75B | 18.19 |
DHR
Danaher Corp
|
174.04 | 123.97B | 24.78B | 3.68B | 5.29B | 5.1743 |
IDXX
Idexx Laboratories Inc
|
563.12 | 45.07B | 4.30B | 1.06B | 1.04B | 13.08 |
A
Agilent Technologies Inc
|
112.18 | 32.36B | 7.07B | 1.29B | 993.00M | 4.5355 |
NTRA
Natera Inc
|
211.56 | 29.60B | 2.31B | -208.16M | 76.11M | -1.5366 |
Illumina Inc Stock (ILMN) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-08-12 | ダウングレード | Daiwa Securities | Outperform → Neutral |
| 2025-07-11 | ダウングレード | Scotiabank | Sector Outperform → Sector Perform |
| 2025-03-04 | 繰り返されました | Citigroup | Neutral |
| 2025-02-28 | ダウングレード | HSBC Securities | Buy → Hold |
| 2025-02-10 | ダウングレード | Barclays | Equal Weight → Underweight |
| 2025-02-07 | ダウングレード | TD Cowen | Buy → Hold |
| 2024-12-11 | ダウングレード | Citigroup | Buy → Neutral |
| 2024-11-12 | 再開されました | Morgan Stanley | Equal-Weight |
| 2024-10-17 | アップグレード | HSBC Securities | Hold → Buy |
| 2024-08-28 | アップグレード | Argus | Hold → Buy |
| 2024-08-16 | アップグレード | Daiwa Securities | Neutral → Buy |
| 2024-08-14 | アップグレード | Barclays | Underweight → Equal Weight |
| 2024-08-14 | アップグレード | TD Cowen | Hold → Buy |
| 2024-07-10 | アップグレード | Citigroup | Neutral → Buy |
| 2024-06-03 | 再開されました | Jefferies | Hold |
| 2024-01-16 | ダウングレード | HSBC Securities | Buy → Hold |
| 2024-01-04 | ダウングレード | TD Cowen | Outperform → Market Perform |
| 2023-12-18 | アップグレード | Scotiabank | Sector Perform → Sector Outperform |
| 2023-12-15 | アップグレード | Bernstein | Underperform → Mkt Perform |
| 2023-12-14 | 開始されました | Guggenheim | Buy |
| 2023-12-14 | 開始されました | Stephens | Overweight |
| 2023-12-13 | 開始されました | Wolfe Research | Outperform |
| 2023-12-12 | ダウングレード | BofA Securities | Neutral → Underperform |
| 2023-12-11 | アップグレード | Citigroup | Sell → Neutral |
| 2023-11-10 | ダウングレード | Canaccord Genuity | Buy → Hold |
| 2023-09-28 | 開始されました | Bernstein | Underperform |
| 2023-07-05 | 再開されました | JP Morgan | Neutral |
| 2023-01-25 | ダウングレード | Argus | Buy → Hold |
| 2023-01-05 | 開始されました | Scotiabank | Sector Perform |
| 2022-12-12 | ダウングレード | Citigroup | Neutral → Sell |
| 2022-12-07 | 開始されました | RBC Capital Mkts | Outperform |
| 2022-10-04 | アップグレード | SVB Leerink | Mkt Perform → Outperform |
| 2022-09-28 | アップグレード | Evercore ISI | In-line → Outperform |
| 2022-08-25 | 開始されました | Credit Suisse | Neutral |
| 2022-07-13 | ダウングレード | Barclays | Equal Weight → Underweight |
| 2022-01-18 | アップグレード | Stifel | Hold → Buy |
| 2022-01-11 | アップグレード | Barclays | Underweight → Equal Weight |
| 2022-01-07 | アップグレード | BofA Securities | Underperform → Neutral |
| 2022-01-06 | 再開されました | Morgan Stanley | Equal-Weight |
| 2022-01-06 | 再開されました | Piper Sandler | Overweight |
| 2021-10-15 | 再開されました | Cowen | Outperform |
| 2021-08-19 | ダウングレード | SVB Leerink | Outperform → Mkt Perform |
| 2021-06-01 | アップグレード | Evercore ISI | Underperform → In-line |
| 2021-03-31 | ダウングレード | Atlantic Equities | Overweight → Neutral |
| 2021-03-31 | アップグレード | Canaccord Genuity | Hold → Buy |
| 2021-03-03 | 開始されました | Barclays | Underweight |
| 2020-12-22 | アップグレード | Piper Sandler | Neutral → Overweight |
| 2020-12-17 | アップグレード | BTIG Research | Neutral → Buy |
| 2020-10-13 | ダウングレード | Guggenheim | Buy → Neutral |
| 2020-09-30 | 開始されました | Atlantic Equities | Overweight |
| 2020-09-29 | ダウングレード | Wolfe Research | Outperform → Peer Perform |
| 2020-09-22 | ダウングレード | Stifel | Buy → Hold |
| 2020-09-22 | ダウングレード | UBS | Buy → Neutral |
| 2020-09-21 | アップグレード | Guggenheim | Neutral → Buy |
| 2020-09-21 | ダウングレード | JP Morgan | Overweight → Neutral |
| 2020-09-09 | 開始されました | Morgan Stanley | Equal-Weight |
| 2020-08-07 | ダウングレード | Evercore ISI | In-line → Underperform |
| 2020-08-07 | ダウングレード | Piper Sandler | Overweight → Neutral |
| 2020-07-07 | ダウングレード | Guggenheim | Buy → Neutral |
| 2020-04-24 | ダウングレード | Citigroup | Buy → Neutral |
| 2020-04-21 | ダウングレード | Robert W. Baird | Outperform → Neutral |
| 2020-01-08 | 開始されました | Wells Fargo | Underweight |
| 2020-01-07 | 開始されました | Citigroup | Buy |
| 2020-01-02 | ダウングレード | Evercore ISI | Outperform → In-line |
| 2019-11-15 | 開始されました | Stifel | Buy |
| 2019-10-25 | 開始されました | Guggenheim | Buy |
すべてを表示
Illumina Inc (ILMN) 最新ニュース
Illumina, Inc. Q1 2026 Financial Report: Earnings, Revenue, Risk Factors & Forward-Looking Statements 18 24 37 - Minichart
Illumina Partners with Florida State University Lab for Rare Disease Genome Sequencing - Clinical Lab Products
Genomics Market size is anticipated to reach US$ 83.61 billion - openPR.com
Illumina (ILMN) Q1 2026 Earnings: Revenue Beat and Raised GuidanceNews and Statistics - IndexBox
Illumina, Inc. 2026 Q1ResultsEarnings Call Presentation (NASDAQ:ILMN) 2026-05-03 - Seeking Alpha
ILMN Q1 Deep Dive: Clinical Sequencing Fuels Growth as NovaSeq X Demand Surges - Yahoo Finance
Illumina revenue up 4.8% to USD 1.09B in Q1 2026 - Medical Buyer
Jennison Associates LLC Has $26.21 Million Stock Position in Illumina, Inc. $ILMN - MarketBeat
[10-Q] ILLUMINA, INC. Quarterly Earnings Report - Stock Titan
Illumina Inc. stock outperforms competitors on strong trading day - MarketWatch
Illumina jumps 7.1% as Q1 results top expectations and full-year outlook rises - Quiver Quantitative
Illumina (NASDAQ:ILMN) Stock Price Expected to Rise, JPMorgan Chase & Co. Analyst Says - MarketBeat
Here’s Why Illumina Stock Could Deliver 8% Annual Returns Through 2028 - TIKR.com
Canaccord cuts Illumina stock price target on competition concerns - Investing.com UK
Illumina, Inc. (NASDAQ:ILMN) Q1 2026 Earnings Call Transcript - Insider Monkey
Canaccord cuts Illumina stock price target on competition concerns By Investing.com - Investing.com Canada
Illumina Q1 2026 earnings preview - MSN
Evercore ISI raises Illumina stock price target on strong results By Investing.com - Investing.com Canada
Evercore ISI raises Illumina stock price target on strong results - Investing.com
Florida Hospital Association adds Gaye Walker as communications VP - Florida Politics
MSN Money - MSN
Illumina (NASDAQ:ILMN) Releases Earnings Results, Beats Estimates By $0.10 EPS - MarketBeat
Illumina (ILMN) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates - Yahoo News Malaysia
Illumina Q1 Earnings Call Highlights - Yahoo Finance
Illumina Q1 2026 slides: earnings beat on clinical strength, margins expand - Investing.com India
Illumina (ILMN) Q1 2026 Earnings Transcript - AOL.com
Illumina (ILMN) Tops Q1 Earnings and Revenue Estimates - Yahoo Finance
Illumina (NASDAQ:ILMN) Issues FY 2026 Earnings Guidance - MarketBeat
Earnings call transcript: Illumina beats Q1 2026 estimates, stock rises - Investing.com
Earnings call transcript: Illumina beats Q1 2026 estimates, stock rises By Investing.com - Investing.com South Africa
Illumina (NASDAQ:ILMN) Posts Better-Than-Expected Sales In Q1 CY2026 - TradingView
Illumina lifts 2026 outlook and expands share buybacks - TipRanks
Illumina Q1 Non-GAAP Earnings, Revenue Rise; Raises 2026 Outlook - marketscreener.com
(ILMN) Illumina Expects Fiscal 2026 Adjusted EPS Range $5.15-$5.30, vs. FactSet Est of $5.12 - marketscreener.com
Illumina: Q1 Earnings Snapshot - marketscreener.com
Earnings Flash (ILMN) Illumina, Inc. Reports Q1 Revenue $1.09B, vs. FactSet Est of $1.07B - marketscreener.com
[8-K] ILLUMINA, INC. Reports Material Event - Stock Titan
Tranche Update on Illumina, Inc.'s Equity Buyback Plan announced on November 6, 2024. - marketscreener.com
Illumina Reports Financial Results for First Quarter of Fiscal Year 2026 - PR Newswire
Tempus AI vs. Illumina: Which Oncology Stock Is Worth Buying Now? - Yahoo Finance
Illumina set to report earnings amid rising Roche competition By Investing.com - Investing.com Australia
Vanguard reports 7.94M shares in Illumina (ILMN) Schedule 13G - Stock Titan
Illumina Inc. Stock (US4523271090): Q1 2026 Earnings Release Expected Today - AD HOC NEWS
Illumina, Inc. $ILMN Shares Sold by Pictet Asset Management Holding SA - MarketBeat
Vanguard Group Inc. Lowers Stake in Illumina, Inc. $ILMN - MarketBeat
ILMN Stock Price, Quote & Chart | ILLUMINA INC (NASDAQ:ILMN) - ChartMill
Illumina Inc. stock underperforms Wednesday when compared to competitors - MarketWatch
Discipline and Rules-Based Execution in ILMN Response - Stock Traders Daily
Illumina (ILMN) Q1 Earnings Report Preview: What To Look For - Yahoo Finance
Will DRAGEN v4.5’s ML-Powered Genomics Upgrade Reshape Illumina’s (ILMN) Precision Medicine Narrative? - Yahoo Finance
Unlocking Q1 Potential of Illumina (ILMN): Exploring Wall Street Estimates for Key Metrics - Yahoo Finance
Illumina Inc (ILMN) 財務データ
収益
当期純利益
現金流量
EPS
0.61%
2.01%
大文字化:
|
ボリューム (24 時間):